Feedback
Settings

Settings

Goto Application

1. WO1999008661 - CONTROLLED RELEASE DOSAGE FORMS CONTAINING WATER SOLUBLE DRUGS

PermaLink
Publication Number WO/1999/008661
Publication Date 25.02.1999
International Application No. PCT/US1998/010184
International Filing Date 18.05.1998
Chapter 2 Demand Filed 12.03.1999
IPC
A61K 9/16 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
16Agglomerates; Granulates; Microbeadlets
A61K 9/20 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
CPC
A61K 9/1617
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1605Excipients; Inactive ingredients
1617Organic compounds, e.g. phospholipids, fats
A61K 9/1652
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1605Excipients; Inactive ingredients
1629Organic macromolecular compounds
1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
A61K 9/2077
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2072characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Applicants
  • FUISZ TECHNOLOGIES LTD. [US]/[US] (AllExceptUS)
  • SANGHVI, Pradeepkumar, P. [IN]/[US] (UsOnly)
  • MISRA, Tushar, K. [IN]/[US] (UsOnly)
  • PRIOR, David, V. [GB]/[US] (UsOnly)
Inventors
  • SANGHVI, Pradeepkumar, P.
  • MISRA, Tushar, K.
  • PRIOR, David, V.
Agents
  • NOLAN, Sandra, M.
Priority Data
08/914,33915.08.1997US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) CONTROLLED RELEASE DOSAGE FORMS CONTAINING WATER SOLUBLE DRUGS
(FR) FORME DE DOSES RETARD CONTENANT DES MEDICAMENTS HYDROSOLUBLES
Abstract
(EN) Controlled release dosage units containing water soluble active agents can be made using an active agent, an optional inert carrier, a cellulosic polymer and a lipophilic ingredient.
(FR) La présente invention concerne des doses retard contenant des principes actifs hydrosolubles. Ces doses retard peuvent se réaliser en utilisant un principe actif, éventuellement un excipient inerte, un polymère cellulosique et un ingrédient lipophile.
Related patent documents
US5851555
EP0994699
CA2297240
AU1998075785
JP2001515030
Latest bibliographic data on file with the International Bureau
# -